Eastman Chemical (EMN) Common Equity (2009 - 2026)

Eastman Chemical (EMN) has reported Common Equity for 18 consecutive years, with $12.6 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 113.04% year-over-year to $12.6 billion; the trailing twelve-month figure through Jun 2026 stood at $12.6 billion (up 113.04% YoY), and the FY2025 full-year result was $12.4 billion, up 112.7% from the prior year.
• Common Equity rose to $12.6 billion in Q2 2026 per EMN's latest filing, from $12.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $12.6 billion in Q2 2026 and bottomed at $5.2 billion in Q4 2022.
• Historically, Common Equity has averaged $7.1 billion across 5 years, with a median of $5.7 billion in 2024.
• The sharpest annual moves came in 2023 and 2025: Common Equity fell 11.96% in 2023, then soared 113.98% in 2025.
• Over 5 years, Common Equity stood at $5.2 billion in 2022, then advanced by 5.61% to $5.5 billion in 2023, then rose by 5.82% to $5.9 billion in 2024, then jumped by 112.7% to $12.4 billion in 2025, then grew by 1.08% to $12.6 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $12.6 billion, $12.5 billion, and $12.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.